T1	Participants 253 291	patients with overactive bladder (OAB)
T2	Participants 137 155	overactive bladder
T3	Participants 392 547	patients with continuous OAB symptoms for ≥ 3 months, daily mean voiding frequency (DMVF) ≥ 8, and daily mean urgency or urgency incontinence frequency ≥ 2
